Asthma clinical trials
The registry lists 4,841 studies for Asthma across more than 10 countries. 600 are recruiting or about to start. 4,235 of them are mainly about Asthma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Asthma, Exercise-Induced: 4,890 studies, 602 open.
ClinicalTrials.gov finds 5,312 studies for Asthma. How that becomes 4,839 here
This page counts the studies the registry files under Asthma, and those it files under no condition that list Asthmathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count
- 5,312Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −49Filed under a narrower condition, counted on its own pageAsthma, Exercise-Induced 32 · Status Asthmaticus 17
- −250List Asthma as a condition, but the registry did not file them under itMost often written as “Asthma in Children” (53), “Allergic Asthma” (33), and “Severe Eosinophilic Asthma” (15). The registry filed them under other conditions only, most often Pulmonary Eosinophilia (40) and Rhinitis, Allergic (37).
- −174Match it another way113 name it in the title, 21 in a keyword, and 40 by a synonym or other text the search reads.
- 4,839The count on this page372 of them list Asthma in their own words; the registry filed them under no condition.
Get an email when these change. Save the Asthma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
AstraZeneca (330) · GlaxoSmithKline (261) · Novartis Pharmaceuticals (81) · National Heart, Lung, and Blood Institute (NHLBI) (76) · Chiesi Farmaceutici S.p.A. (66) · Organon and Co (62) · Boehringer Ingelheim (62) · Teva Branded Pharmaceutical Products R&D, Inc. (46)
What is being tested here
Drugs under test in Asthma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Dupilumab | 7 | 11 | 31 |
| Tezepelumab | 7 | 15 | 27 |
| Budesonide | 6 | 51 | 108 |
| Albuterol | 5 | 14 | 66 |
| Benralizumab | 3 | 20 | 37 |
| Depemokimab | 3 | 7 | 10 |
| Tilrekimig | 3 | 2 | 3 |
| Formoterol | 2 | 47 | 81 |
| Omalizumab | 2 | 19 | 59 |
| Mepolizumab | 2 | 11 | 28 |
Drug classes tested here Corticosteroids 10 open · Bronchodilators 8 open · Antimuscarinics 3 open · Tyrosine kinase inhibitors (TKIs) 1 open · JAK inhibitors 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites · Phase 3 · Inmunotek S.L.
- Dec 2026A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma · Phase 3 · AstraZeneca
- Dec 2026A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a) · Phase 3 · GlaxoSmithKline
- Dec 2026A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations · Phase 3 · Teva Branded Pharmaceutical Products R&D LLC
- Jan 2027A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma · Phase 3 · GlaxoSmithKline
- Feb 2027Efficacy and Safety Study of 610 in Patients With Severe Asthma · Phase 3 · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Mar 2027A Study of Depemokimab in Participants of 6 to 11 Years of Age · Phase 3 · GlaxoSmithKline
- May 2027The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants · Phase 3 · University of Melbourne
- Jun 2027Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. · Phase 3 · AstraZeneca
- Jun 2027A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets) · Phase 3 · The First Affiliated Hospital with Nanjing Medical University
Who these studies take
Of the 417 Asthma studies recruiting now, 140 (34%) set no upper age limit and 205 (49%) stop at 75 or younger. 146 (35%) take children under 18. 4 (1%) are for women only and 0 (0%) for men only; 104 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 101 (24%) | 101 (24%) |
| 18 | 326 (78%) | 323 (77%) |
| 30 | 331 (79%) | 327 (78%) |
| 40 | 332 (80%) | 329 (79%) |
| 50 | 320 (77%) | 320 (77%) |
| 65 | 301 (72%) | 301 (72%) |
| 75 | 256 (61%) | 256 (61%) |
| 85 | 187 (45%) | 187 (45%) |
Across all 4,841 studies, recruiting or not: 61% stop at 75 or younger and 50% at 65; 42% take children; 1% are for women only and 2% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Asthma studies take
Of 205 phase 3 interventional studies under Asthma, half reached primary completion within 27 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 6 mo3–14 · 200 studies | 5 mo3–12 · 173 studies | — |
| Phase 2 | 20 mo12–41 · 198 studies | 16 mo10–23 · 137 studies | 46 mo28–62 · 61 studies |
| Phase 2/3 | 28 mo12–59 · 14 studies | — | — |
| Phase 3 | 27 mo14–42 · 205 studies | 25 mo14–41 · 173 studies | 35 mo18–54 · 32 studies |
| Phase 4 | 24 mo11–37 · 156 studies | 21 mo9–33 · 66 studies | 27 mo12–41 · 90 studies |
| Interventional, no phase | 23 mo10–48 · 649 studies | 12 mo5–24 · 50 studies | 24 mo11–50 · 599 studies |
| Observational | 36 mo18–82 · 454 studies | 28 mo17–58 · 90 studies | 38 mo18–97 · 364 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting7
- THERMotherapy Against Persistent Bacterial LUNG InfectionsNov 6, 2026NCT05351242
- A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe AsthmaNov 3, 2026NCT07746687
- Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in CanadaOct 26, 2026NCT07536178
- Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe AsthmaOct 21, 2026NCT07120503
- Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma ExacerbationsOct 19, 2026NCT07112456
Show 2 moreShow fewer
- A Study to Understand the Accuracy of a New Breathing Device Compared to Standard Testing for Asthma and COPDOct 15, 2026NCT07253883
- Evaluation of Safety, Side Effects, and How the Drug, Inhaled CHF10136, Is Absorbed, Modified and Removed From the Body in Healthy Adults and Adults With AsthmaOct 13, 2026NCT07851623
Results posted4
- A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent AsthmaNov 10, 2026NCT01987492
- Non-Eosinophilic Biological Effects of IL-5Nov 6, 2026NCT06026202
- Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma: Influence of Systemic IL-5 TargetingNov 5, 2026NCT05689931
- Feasibility and Acceptability of the Propeller Monitoring System in Children With Persistent AsthmaOct 19, 2026NCT03648450
Stopped2
- A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent AsthmaTerminatedNov 10, 2026NCT01987492
- Probiotics and Insulin Resistance in Obese AsthmaticsTerminatedNov 5, 2026NCT05949255
Newly registered13
- Chronic Respiratory Disease Participant Engagement StudyNov 9, 2026NCT07924462
- Bronchial Hyperresponsiveness in SarcoidosisNov 5, 2026NCT07919665
- Reducing Exposure With Air Cleaners and TechnologyNov 3, 2026NCT07914010
- Construction and Validation of an Impulse Oscillometry (IOS)-Based Platform for Screening, Diagnosis, and Management of Chronic Airway DiseasesNov 2, 2026NCT07910409
- Perception of the Benefits and Effectiveness of Inhalation Therapy in Patients With Obstructive DyspneaOct 29, 2026NCT07903597
Show 8 moreShow fewer
- Asthma and Primary Arterial Hypertension: an Inflammatory Link?Oct 29, 2026NCT07903805
- A Study of HB0056 in Adult Participants With Moderate to Severe AsthmaOct 28, 2026NCT07899996
- Study of HXN-1013 in Healthy Participants and Participants With Mild-to-Moderate AsthmaOct 28, 2026NCT07900568
- R34 Asthma DepressionOct 26, 2026NCT07895576
- Prevelance of Bronchial Asthma and Allergic Rhinitis Among Children With Nephrotic Syndrom at Sohag University HospitalOct 26, 2026NCT07896291
- A Randomized, Double-Blind, Placebo-Controlled Phase Ib Study of Multiple Ascending Doses of EB070 Injection in Adults With Moderate-to-Severe AsthmaOct 21, 2026NCT07886710
- Effects of Respiratory Muscle Strength Training in Children With AsthmaOct 19, 2026NCT07880145
- Changing Lifestyle to Improve Quality of Life in Spanish Adolescents With AsthmaOct 13, 2026NCT07870980
Studies
Recruiting first, then most recently updated. Showing 50 of 4,841. Browse all 4,841 → or search them.
- Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued TreatmentRecruitingNCT07444567Phase 314 countries
- Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaRecruitingNCT06307665Phase 34 countries
- A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With AsthmaRecruitingNCT05562466Phase 317 countries
- A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaRecruitingNCT06023589Phase 322 countries
- A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)RecruitingNCT07276724Phase 321 countries
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With AsthmaRecruitingNCT05222529Phase 28 countries
- Advancing Diagnosis and Treatment of Pediatric AsthmaRecruitingNCT07500246Not applicable2 countries
- A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.RecruitingNCT05776927Phase 310 countries
- Pulmonary Rehabilitation in African CountriesNot yet recruitingNCT07602673Not applicable3 countries
- A Multicentre, Single Arm, Non-interventional, Real-world Study to Assess Demographic Characteristics and Patient Reported Outcomes in Patients With Severe Eosinophilic Asthma Treated With Benralizumab in ChinaRecruitingNCT068622061 country
- Role of Genetic Factors in the Development of Lung DiseaseRecruitingNCT000015321 country
- Chronic Respiratory Disease Participant Engagement StudyRecruitingNCT079244621 country
- A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in AsthmaRecruitingNCT07309614Phase 33 countries
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaRecruitingNCT06977581Phase 215 countries
- Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway InflammationRecruitingNCT00595491Phase 11 country
- A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 InclusiveRecruitingNCT06433921Phase 11 country
- THERMotherapy Against Persistent Bacterial LUNG InfectionsRecruitingNCT05351242Not applicable1 country
- Reducing Exposure With Air Cleaners and TechnologyNot yet recruitingNCT07914010Not applicable1 country
- A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)RecruitingNCT07782996Phase 31 country
- Novel Method for Removal of Orally Deposited Inhaled Fluticasone PropionateNot yet recruitingNCT07664527Phase 41 country
- A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaRecruitingNCT07219173Phase 212 countries
- A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe AsthmaRecruitingNCT07869043Phase 32 countries
- A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical PracticeRecruitingNCT075561596 countries
- A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)RecruitingNCT07645248Phase 34 countries
- Rademikibart IV for Acute Asthma and COPD ExacerbationRecruitingNCT07705737Phase 21 country
- Asthma Ctrl SMART TrialNot yet recruitingNCT07512622Not applicable1 country
- Phase 3b Study in Patients With Severe Asthma Treated With TezepelumabRecruitingNCT07363642Phase 31 country
- A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate AsthmaRecruitingNCT07660731Phase 12 countries
- A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe AsthmaRecruitingNCT07746687Phase 25 countries
- A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)RecruitingNCT07359846Phase 319 countries
- Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)RecruitingNCT06488118Not applicable1 country
- Bilevel Positive Airway Pressure (BPAP) for Severe AsthmaNot yet recruitingNCT07582211Not applicable1 country
- Swiss Severe Asthma RegisterRecruitingNCT039842531 country
- Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)Enrolling by invitationNCT078671841 country
- Construction and Validation of an Impulse Oscillometry (IOS)-Based Platform for Screening, Diagnosis, and Management of Chronic Airway DiseasesRecruitingNCT079104091 country
- Asthma and Primary Arterial Hypertension: an Inflammatory Link?RecruitingNCT079038051 country
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe AsthmaRecruitingNCT07772921Phase 32 countries
- Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsRecruitingNCT06932263Phase 221 countries
- Effects of Tele-rehabilitation-Guided Qigong on Children and Adolescents With AsthmaRecruitingNCT07883967Not applicable1 country
- Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control SubjectsRecruitingNCT06015256Not applicable1 country
- Investigating Novel Strategies in Pediatric Immune Responses and Microbiome Environment: Comprehensive Lung Disease Investigation in Children.Enrolling by invitationNCT067460771 country
- Study of HXN-1013 in Healthy Participants and Participants With Mild-to-Moderate AsthmaNot yet recruitingNCT07900568Phase 11 country
- A Study of HB0056 in Adult Participants With Moderate to Severe AsthmaRecruitingNCT07899996Phase 1/21 country
- Prevelance of Bronchial Asthma and Allergic Rhinitis Among Children With Nephrotic Syndrom at Sohag University HospitalNot yet recruitingNCT078962911 country
- Remote Monitoring of Asthma in Children and Young PeopleRecruitingNCT071296161 country
- Allergy, Asthma, and Atopic Eczema in FinlandEnrolling by invitationNCT063309741 country
- NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)RecruitingNCT023278971 country
- Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in CanadaRecruitingNCT07536178Not applicable1 country
- Study of the Effect of Innate on the Inflammatory Response to EndotoxinRecruitingNCT011434801 country
- R34 Asthma DepressionNot yet recruitingNCT07895576Not applicable1 country